Profit with purpose – delivering sustainable impact and attractive returns

Better treatments, Better care, Healthier societies

New frontiers

George
Clinical

Science, service, solutions. A leading contract research organisation in Asia-Pacific with global capabilities.

Novel Treatments

George
Medicines

Innovative, affordable treatments for the leading causes of death globally.

Disruptive technologies

George Health Technologies

Affordable, personalised digital health care for all.

Device Pioneering

Ellen Medical Devices

The world’s first affordable dialysis system.

A leader in global health

The George Institute for Global Health

All the George Health businesses benefit from exclusive access to the research, intellectual property, and scientific expertise of The George Institute for Global Health – a world-leading, global medical research institute focused on the biggest killers: non-communicable diseases and injury.

Non-communicable diseases – a unique 21st century global health challenge

5 billion

5 billion people have no reliable access to essential health care.

100 million

100 million people will die from chronic diseases before they reach 60.
Heart attack and stroke are the world’s leading cause of death.

US$47 trillion

The United Nations has projected cumulative losses to the global economy due to chronic disease could reach US$47 trillion by 2030.

News

 

The George Institute Annual Report 2020

For George Health, 2019 and 2020 were watershed years. Multiple investors stepped forward to complete a capital raise of $53 million to back George Health’s ‘profit with purpose’ vision: improving and lengthening people’s lives, boosting health system sustainability and generating strong financial returns.

Read our year in review in The George Institute’s Annual Report 2020.

If you would like to find out more about partnering with George Health, contact us.